Galindo Sacristán P, Pérez Marfil A, Osorio Moratalla J M, de Gracia Guindo C, Ruiz Fuentes C, Castilla Barbosa Y A, García Jiménez B, de Teresa Alguacil J, Barroso Martin F J, Osuna Ortega A
Department of Nephrology. Hospital Universitario Virgen de las Nieves, Granada, Spain.
Transplant Proc. 2013;45(10):3620-3. doi: 10.1016/j.transproceed.2013.11.009.
Infectious disease, a complication favored by immunosuppression, is the main cause of 1st-year mortality in solid organ transplantation. In renal transplant recipients (RTRs), urinary tract infection (UTI) is the most common, and the microorganisms that are isolated depend on chronology.
We present an observational study comprising 129 RTRs from January 2010 to December 2011 who were followed during the 1st year after transplantation. We analyzed occurrence of infections, predisposing factors, timing, severity, site of infection, and microorganisms.
The patients had a total of 424 infectious episodes during the 1st year (3.29 episodes/patient/year). The predominant focus was the urinary tract, with at least 1 episode in 69.8% of patients. Bacteremia was recorded in 25.6% of patients and surgical wound infection in 20.9%. Cytomegalovirus infection or disease was diagnosed in 46.5%. Severe infections occurred in 30.2%. The predominant pathogen was E. coli. There was a significant correlation between hospital stay and the number of infections (P = .000; r = 0.407) and between body mass index and hospital stay (P = .001; r = 0.282). Severe infections were more frequent in diabetics, patients with a double-J stent, and those treated with basiliximab. Patients with cytomegalovirus replication had a higher number of infections (4.1 ± 1.2 vs 2.5 ± 5; P = .000) and significantly higher annual serum creatinine (1.65 ± 5.7 vs 1.31 ± 1.3 mg/dL; P = .003).
The prevalence of infections in the 1st year after kidney transplantation is very high, occurring mainly in the early period, in the urinary tract, and due to E. coli. Cytomegalovirus replication is associated with a higher number of infections and higher serum creatinine at 1 year. Body mass index is a predictor of early infection and of bacteremia in the post-transplantation period. Basiliximab induction and having a double-J stent were predictors of severe infections.
感染性疾病是实体器官移植第一年死亡的主要原因,免疫抑制易引发该并发症。在肾移植受者(RTRs)中,尿路感染(UTI)最为常见,分离出的微生物取决于发病时间。
我们开展了一项观察性研究,纳入了2010年1月至2011年12月期间的129例RTRs,在移植后的第一年对其进行随访。我们分析了感染的发生情况、易感因素、时间、严重程度、感染部位和微生物。
患者在第一年共发生424次感染事件(3.29次/患者/年)。主要感染部位是泌尿系统,69.8%的患者至少发生过1次感染。25.6%的患者发生菌血症,20.9%的患者发生手术伤口感染。46.5%的患者被诊断为巨细胞病毒感染或疾病。30.2%的患者发生严重感染。主要病原体是大肠杆菌。住院时间与感染次数之间存在显著相关性(P = 0.000;r = 0.407),体重指数与住院时间之间也存在显著相关性(P = 0.001;r = 0.282)。糖尿病患者、留置双J支架的患者以及接受巴利昔单抗治疗的患者发生严重感染的频率更高。巨细胞病毒复制的患者感染次数更多(4.1±1.2对2.5±5;P = 0.000),且年度血清肌酐显著更高(1.65±5.7对1.31±1.3mg/dL;P = 0.003)。
肾移植后第一年感染的发生率非常高,主要发生在早期,感染部位为泌尿系统,病原体为大肠杆菌。巨细胞病毒复制与一年时感染次数增加和血清肌酐升高有关。体重指数是移植后早期感染和菌血症的预测指标。巴利昔单抗诱导治疗和留置双J支架是严重感染的预测指标。